The Era of New Assisted Reproductive Technology (ART)
Deadline for manuscript submissions: 25 June 2024 | Viewed by 2040
Interests: uterus transplantation; gynecological cancer; Mayer–Rokitansky–Küster–Hauser syndrome; uterine factor infertility; nonhuman primates
Special Issues, Collections and Topics in MDPI journals
Since the birth of Louise Brown in 1978, assisted reproductive technology (ART) has been a mainstay of fertility treatment. Advances in various types of ART have brought the gospel to many infertile couples. In recent years, techniques for transplanting uterine or ovarian tissue have been developed, which are being positioned as an important new procedure for fertility preservation. Furthermore, regenerative medicine for the uterus or vagina and organoid research for female reproductive organs are also underway. In addition, ART is an essential technique for juvenile cancer survivors in order to preserve fertility, including women that have undergone radical trachelectomy for cervical cancer. Thus, the era of new ART has arrived; this technology will be indispensable in the future, bringing advantages to many infertile patients.
This Special Issue welcomes review and original research articles highlighting the recent ART advances in the field of reproductive medicine or gynecological oncology, with the aim of increasing our understanding and addressing future clinical challenges.
Dr. Iori Kisu
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- assisted reproductive technology
- fertility preservation
- uterine factor infertility
- uterus transplantation
- ovarian tissue transplantation
- ovarian tissue cryopreservation
- cervical cancer
- radical trachelectomy
- tissue engineering
- uterine regeneration
- oocyte cryopreservation
- in vitro fertilization